Algorae Pharmaceuticals (ASX:1AI)
ASX announcement history & article coverage
Transparent by design.
Announcments by Algorae Pharmaceuticals (ASX:1AI) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Algorae executes Licence & Supply Agreement with Umedica
Algorae signs Umedica supply deal and advances TGA filing for Australian medicine
Peter Mac partners with Algorae on 3rd AI validation program
Algorae partners with Peter Mac for third AI drug synergy validation program
Notice of Annual General Meeting/Proxy Form
Change of Director's Interest Notice - DH
Date of AGM and Closing Date for Director Nominations
Notification of cessation of securities - 1AI
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
Algorae Pharmaceuticals reports increased net loss and expands commercial operations in FY2026
Quarterly Activities Report/Appendix 4C Cashflow Statement
Algorae Pharmaceuticals expands commercial agreements, advances TGA registrations, scales AI pipeline, and secures NSW Health contract